[Source: Research & Innovation] Academic institutions have always been at the forefront of innovation. Big pharma is facing major patent cliffs and slashing internal R and D budgets, whilst academia is finding it tougher to gain funding for research projects. This means that it is more important than ever for the two groups to establish meaningful and mutually beneficial relationships. Academia Pharma: Development Partnerships successfully creates a unique environment for leading industry professionals to share novel case studies, develop future strategies and most importantly create mutual partnerships to support drug development. The event will bring together an international community of experts from academia, biopharma, healthcare and research institutions and councils to share best practice in collaborative research and development. Topics of discussion include: Start-up to IPO: capitalising on scientific discovery; Influence of I.T. and Big Data on the laboratory; Drug Discovery; Funding Science in an increasingly risk-averse market; Scientific and real-world benefits of collaboration; Penetrating new markets: traditional technology firms and healthcare. Sponsorship packages are available and interested parties should contact: enquiries@academiapharma.com
from EUROPA - Syndicated Research News Feed http://ift.tt/2e48Cmy
via IFTTT
No comments:
Post a Comment